Peptidomimetic GnRH Antagonist AEZS-115 Inhibits the Growth of Ovarian and Endometrial Cancer Cells
Anticancer Research, 05/17/2012
Engel JB et al. – Gonadotropin–releasing hormone (GnRH) antagonist AEZS–115 exhibited substantial antitumor activity in ovarian as well as endometrial cancer cell lines. However, this antitumor effect was not mediated by the tumoral GnRH receptors.